At the news
? MIXEDIMPACT 5/10 8-K filed Jul 8, 2026 at 08:03 ET
Azenta completed the sale of B Medical Systems to Thelema for $63M total consideration, consisting of $28M cash received and a $35M vendor loan secured by a first-priority pledge over B Medical's equity. The vendor loan carries 6.0% interest, matures in three months (October 1, 2026), and is classified as a related-party transaction since Thelema is majority-owned by Luc Provost, a VP of Azenta. The divestiture aligns with Azenta's strategy to focus on core life sciences, but the large vendor loan receivable ($35M) creates near-term credit risk and tied-up capital.
- Sale of B Medical Systems completed July 1, 2026 for fixed $63M total consideration.
- $28M cash received ($9M deposit from Dec 2025 + $19M at closing); $35M funded via secured vendor loan at 6.0% p.a., maturing in 3 months.
- Thelema, the buyer, is majority-owned by Luc Provost (Azenta VP and CEO of B Medical); Audit Committee approved the related-party transaction.
- Pro forma balance sheet shows cash increases by ~$19M to $253M, a $35M short-term note receivable, and a $41.5M reduction in retained earnings (cumulative translation + costs to sell).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access